These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14529537)

  • 41. [Reaction of enzyme-labeled antibodies in the immunodiagnosis of parasitic diseases. 5. A test system for the diagnosis of fascioliasis].
    Martynenko LD; Lysenko AIa; Vasil'ev VI
    Med Parazitol (Mosk); 1982; 51(6):41-6. PubMed ID: 6759902
    [No Abstract]   [Full Text] [Related]  

  • 42. The laboratory diagnosis of tropical diseases with special reference to Britain: a review.
    Ridley DS
    J Clin Pathol; 1974 Jun; 27(6):435-44. PubMed ID: 4213454
    [No Abstract]   [Full Text] [Related]  

  • 43. Enzyme-linked immunosorbent assay (ELISA) for the detection of antibody to cysticerci of Taenia solium.
    Diwan AR; Coker-Vann M; Brown P; Subianto DB; Yolken R; Desowitz R; Escobar A; Gibbs CJ; Gajdusek DC
    Am J Trop Med Hyg; 1982 Mar; 31(2):364-9. PubMed ID: 7072900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antigens from Taenia crassiceps cysticerci used in complement fixation, enzyme-linked immunosorbent assay, and western blot (immunoblot) for diagnosis of neurocysticercosis.
    Garcia E; Ordoñez G; Sotelo J
    J Clin Microbiol; 1995 Dec; 33(12):3324-5. PubMed ID: 8586728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of specific Fasciola antigen in the immunodiagnosis of human fascioliasis in Egypt.
    Shaker ZA; Demerdash ZA; Mansour WA; Hassanein HI; el Baz HG; el Gindy HI
    J Egypt Soc Parasitol; 1994 Dec; 24(3):463-70. PubMed ID: 7844410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seroprevalence of fascioliasis, toxocariasis, strongyloidiasis and cysticercosis in blood samples diagnosed in Medic Medical Center Laboratory, Ho Chi Minh City, Vietnam in 2012.
    Nguyen T; Cheong FW; Liew JW; Lau YL
    Parasit Vectors; 2016 Sep; 9(1):486. PubMed ID: 27595647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The serologic diagnosis of parasitic infections in medical practice.
    Miller LH; Brown HW
    Ann Intern Med; 1969 Nov; 71(5):983-92. PubMed ID: 4982812
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of excretory/secretory Fasciola (Fhes) antigen in diagnosis of human fascioliasis.
    Haseeb AN; el-Shazly AM; Arafa MA; Morsy AT
    J Egypt Soc Parasitol; 2003 Apr; 33(1):123-38. PubMed ID: 12739806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunodiagnosis of human fascioliasis by an enzyme-linked immunosorbent assay (ELISA) and a micro-ELISA.
    Carnevale S; Rodríguez MI; Santillán G; Labbé JH; Cabrera MG; Bellegarde EJ; Velásquez JN; Trgovcic JE; Guarnera EA
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):174-7. PubMed ID: 11139214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fundamentals of immunodiagnosis exemplified by parasitic infections].
    Weiss N
    Ther Umsch; 1990 Oct; 47(10):833-8. PubMed ID: 2260024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of the EVI antibody in parasitic diseases other than American trypanosomiasis. An anti-skeletal muscle antibody in leishmaniasis.
    Szarfman A; Khoury EL; Cossio PM; Arana RM; Kagan IG
    Am J Trop Med Hyg; 1975 Jan; 24(1):19-24. PubMed ID: 1089366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunodiagnosis of schistosomiasis.
    Tsang VC; Wilkins PP
    Immunol Invest; 1997; 26(1-2):175-88. PubMed ID: 9037622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune response to parasitic infections--an introduction.
    Brandonisio O; Spinelli R
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Oct; 2(3):193-9. PubMed ID: 12476485
    [No Abstract]   [Full Text] [Related]  

  • 54. Epidemiological, clinical and laboratory studies on parasitic infections as a cause of fever of undetermined origin in Dakahlia Governorate, Egypt.
    Aboul-Hassan S; el-Shazly AM; Farag MK; Habib KS; Morsy TA
    J Egypt Soc Parasitol; 1997 Apr; 27(1):47-57. PubMed ID: 9097526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular diagnostics and parasitic disease.
    Vasoo S; Pritt BS
    Clin Lab Med; 2013 Sep; 33(3):461-503. PubMed ID: 23931835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoserology in parasitic infections.
    Walls KW; Wilson M
    Lab Res Methods Biol Med; 1983; 8():191-214. PubMed ID: 6358742
    [No Abstract]   [Full Text] [Related]  

  • 57. Specific immunodiagnosis of human hydatidosis by the enzyme linked immunosorbent assay (E.L.I.S.A.).
    Farag H; Bout D; Capron A
    Biomedicine; 1975 Sep; 23(7):276-8. PubMed ID: 782577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Current status in research on the immunodiagnosis of parasitic diseases].
    Li YH
    Zhonghua Nei Ke Za Zhi; 1988 Jul; 27(7):446-8. PubMed ID: 3146487
    [No Abstract]   [Full Text] [Related]  

  • 59. Cysticercosis: towards the design of a diagnostic kit based on synthetic peptides.
    Hernández M; Beltrán C; García E; Fragoso G; Gevorkian G; Fleury A; Parkhouse M; Harrison L; Sotelo J; Sciutto E
    Immunol Lett; 2000 Jan; 71(1):13-7. PubMed ID: 10709780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthetic peptides for the immunodiagnosis of human diseases.
    Gómara MJ; Haro I
    Curr Med Chem; 2007; 14(5):531-46. PubMed ID: 17346145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.